John R Desjarlais - Net Worth and Insider Trading
John R Desjarlais Net Worth
The estimated net worth of John R Desjarlais is at least $3 Million dollars as of 2023-10-04. John R Desjarlais is the SR. VICE PRESIDENT & CSO of Xencor Inc and owns about 147,726 shares of Xencor Inc (XNCR) stock worth over $3 Million. Details can be seen in John R Desjarlais's Latest Holdings Summary section.
Transaction Summary of John R Desjarlais
John R Desjarlais Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John R Desjarlais owns 1 companies in total, including Xencor Inc (XNCR) .
Click here to see the complete history of John R Desjarlais’s form 4 insider trades.
Insider Ownership Summary of John R Desjarlais
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XNCR | Xencor Inc | 2023-03-02 | SR. VICE PRESIDENT & CSO |
John R Desjarlais Latest Holdings Summary
John R Desjarlais currently owns a total of 1 stock. John R Desjarlais owns 147,726 shares of Xencor Inc (XNCR) as of March 9, 2023, with a value of $3 Million.
Latest Holdings of John R Desjarlais
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XNCR | Xencor Inc | 2023-03-09 | 147,726 | 19.60 | 2,895,430 |
Holding Weightings of John R Desjarlais
John R Desjarlais Form 4 Trading Tracker
According to the SEC Form 4 filings, John R Desjarlais has made a total of 7 transactions in Xencor Inc (XNCR) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Xencor Inc is the sale of 1,230 shares on March 9, 2023, which brought John R Desjarlais around $36,752.
Insider Trading History of John R Desjarlais
- 1
John R Desjarlais Trading Performance
John R Desjarlais Ownership Network
Ownership Network List of John R Desjarlais
Ownership Network Relation of John R Desjarlais
John R Desjarlais Owned Company Details
What does Xencor Inc do?
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045 and XmAb13676. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
Who are the key executives at Xencor Inc?
John R Desjarlais is the SR. VICE PRESIDENT & CSO of Xencor Inc. Other key executives at Xencor Inc include director & PRESIDENT & CEO Bassil I Dahiyat , VP & GENERAL COUNSEL Celia Eckert , and SR. VICE PRESIDENT & CFO John J Kuch .
Xencor Inc (XNCR) Insider Trades Summary
Over the past 18 months, John R Desjarlais made 3 insider transaction in Xencor Inc (XNCR) with a net sale of 6,657. Other recent insider transactions involving Xencor Inc (XNCR) include a net sale of 44,781 shares made by Bassil I Dahiyat , a net sale of 8,900 shares made by Allen Yang , and a net sale of 4,404 shares made by John J Kuch .
In summary, during the past 3 months, insiders sold 0 shares of Xencor Inc (XNCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 68,342 shares of Xencor Inc (XNCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 68,342 shares.
Xencor Inc (XNCR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xencor Inc Insider Transactions
John R Desjarlais Mailing Address
Above is the net worth, insider trading, and ownership report for John R Desjarlais. You might contact John R Desjarlais via mailing address: C/o Xencor, Inc., 111 West Lemon Avenue, Monrovia Ca 91016.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
